|« Don't Lose Sleep Over Daylight Savings Time||Federal Health Care Cost Estimate Raises Eyebrows »|
The Wall Street Journal Health Blog reports that only 10% of coronary stent recipients are given information on alternative treatment options, based on a survey of nearly 500 Medicare patients.
The study – which, it should be noted, was based solely on the patient’s recollection of events – also found that only 19% of coronary stent recipients recalled discussing the drawbacks of the procedure, and only 16% recalled being asked their preferences for treatment type.
A coronary stent is a tube placed in the heart arteries to keep the vessels open. According to Reuters Health, stenting procedures cost the United States about $12 billion every year and up to half of the procedures are unnecessary.
At MedBen, we promote informed heart treatment through Comprehensive Cardiovascular Care Management. Provided through inVentiv Care Management, this clinically accountable solution focuses on cost-effective, safe, and integrated care management for patients affected by cardiovascular disease.
Care management does not and will not overrule the decisions of a patient’s physician. It merely works with the doctor to ensure that the patient is receiving the proper level of treatment, and that his or her care is eligible for coverage under your company’s health care plan.
For additional information about Comprehensive Cardiovascular Care Management and other Accountable Care Solutions available through MedBen, contact Vice President of Sales and Marketing Brian Fargus at (888) 627-8683.